FOUNDATION FIGHTING BLINDNESS INC
- Health & Medicine
- People with Disabilities
Location6925 OAKLAND MILLS RDSuite 701COLUMBIA, MD 21045 United States
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.
The Foundation Fighting Blindness was established in 1971 by a passionate group of families driven to find treatments and cures for inherited retinal diseases that were affecting their loved ones. At that time, little was known about these blinding retinal degenerative diseases. Very little research was being done, and there were no clinical trials for potential treatments.
The Foundation’s goal was clear and focused: To drive the research that would lead to preventions, treatments, and vision restoration for the spectrum of degenerative retinal diseases, specifically macular degeneration - including age related macular degeneration, retinitis pigmentosa, Usher syndrome, Stargardt disease and Leber congenital amaurosis (LCA). Together these conditions affect more than 10 million Americans and millions more throughout the world.
Today, the Foundation Fighting Blindness is the world’s leading private funder of retinal disease research. That funding has been a driving force behind the progress toward cures, including the identification of more than 270 genes linked to retinal disease, and the launch of 42 clinical trials for potential treatments.
On an annual basis, the Foundation Fighting Blindness and the Foundation’s Clinical Research Institute fund more than 90 research grants. The research projects are conducted by more than 150 research investigators at institutions, eye hospitals, and universities in the United States, Australia, England, France, Germany, The Netherlands, Italy, Israel, and Mexico.